Leukemia Clinical Trials in San Diego

Showing 1121-1140 of 1,204 trials

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

NCT00066599

RATIONALE: Voriconazole may be effective in preventing systemic fungal infections following chemotherapy. PURPOSE: Phase II trial to study the effectiveness of voriconazole in preventing systemic fungal infections in children who have neutropenia after receiving chemotherapy for leukemia, lymphoma, or aplastic anemia or in preparation for bone marrow or stem cell transplantation.

Kidney CancerLeukemiaLymphoma+6 more

National Cancer Institute (NCI)Started Jun 2003

Orange, California, United States • San Diego, California, United States • Bethesda, Maryland, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)

NCT00464633

Multicenter, open-label, study of alvocidib in previously treated chronic lymphocytic leukemia patients. Primary objective is to determine overall response rate. The secondary objectives are: * to assess overall safety, * to assess duration of response, progression free survival, and overall survival. Clinical benefit and pharmacokinetics parameters are also evaluated.

Leukemia, Lymphocytic, Chronic

Sanofi165 participantsStarted Mar 2007

San Diego, California, United States • San Francisco, California, United States • Chicago, Illinois, United States +31 more locations

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)

Leukemia Trials in Other Cities

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

Iressa Expanded Access Program (EAP)

STD Risk Reduction for Heterosexual Methamphetamine Users

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

Topotecan in Treating Children With Refractory Leukemia

Share Safer Sex Counseling Program for Changing Sexual Risk Behaviors in Mexican Female Sex Workers

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

S9912 Combination Chemo in Stage III Ovarian Cancer,

A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Other Conditions in San Diego